Vir Biotechnology, INC. (VIR) SEC Filings — 2024
21 SEC filings for Vir Biotechnology, INC. (VIR) in 2024.
Filings
- Vir Biotechnology Files Q3 2024 10-Q — 10-Q · Nov 4, 2024
- Vir Biotechnology Files 8-K on Financials — 8-K · Oct 31, 2024
- Vir Biotechnology, INC. SC 13G/A Filing — SC 13G/A · Oct 18, 2024
- Vir Biotechnology Director Departs Board — 8-K · Sep 10, 2024
- Vir Biotechnology Enters Material Definitive Agreement — 8-K · Aug 1, 2024
- Vir Biotechnology 10-Q: Q2 2024 Update — 10-Q · Aug 1, 2024
- Vir Biotechnology Files 8-K — 8-K · Jun 26, 2024
- Vir Biotechnology Files 8-K — 8-K · Jun 5, 2024
- Vir Biotechnology Files 8-K on Security Holder Vote — 8-K · May 29, 2024
- Vir Biotechnology Files Proxy Materials for 2024 Annual Meeting — DEFA14A · May 14, 2024
- Vir Biotechnology, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 3, 2024
- Vir Biotechnology Files 8-K on Operations and Financials — 8-K · May 2, 2024
- Vir Biotechnology, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 19, 2024
- Vir Biotechnology Files 8-K on Executive and Board Changes — 8-K · Apr 18, 2024
- Vir Biotechnology, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 26, 2024
- Vir Biotechnology Files 8-K on Material Agreement & Financials — 8-K · Feb 22, 2024
- Vir Biotechnology Files 8-K on Officer Changes & Compensation — 8-K · Feb 20, 2024
- Vir Biotechnology, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Vir Biotechnology, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- State Street Corp. Discloses Passive Stake in Vir Biotechnology — SC 13G · Jan 24, 2024
- BlackRock Cuts Vir Biotechnology Stake to 4.3% — SC 13G/A · Jan 23, 2024